Monday August 17, 2026
Section

Business

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
Press Release

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon

Read Full Story